[Can we still justify the use of posterior pituitary hormones in bronchial carcinoma?].
D000818:Animals; D001249:Asthma / Q000188:drug therapy; D001980:Bronchi / Q000187:drug effects; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000188:drug therapy; D004357:Drug Synergism; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D010909:Pituitary Hormones, Posterior / Q000009:adverse effects / Q000627:therapeutic use*; D014132:Trachea / Q000187:drug effects
D010909:Pituitary Hormones, Posterior; D004837:Epinephrine
Ist heute noch die Anwendung von Hypophysenhinterlappenhormonen beim Bronchialkarzinom vertretbar?